TY - JOUR
T1 - Breast MRI
T2 - EUSOBI recommendations for women's information
AU - Mann, Ritse M.
AU - Balleyguier, Corinne
AU - Baltzer, Pascal A.
AU - Bick, Ulrich
AU - Colin, Catherine
AU - Cornford, Eleanor
AU - Evans, Andrew
AU - Fallenberg, Eva
AU - Forrai, Gabor
AU - Fuchsjäger, Michael H.
AU - Gilbert, Fiona J.
AU - Helbich, Thomas H.
AU - Heywang-Köbrunner, Sylvia H.
AU - Camps-Herrero, Julia
AU - Kuhl, Christiane K.
AU - Martincich, Laura
AU - Pediconi, Federica
AU - Panizza, Pietro
AU - Pina, Luis J.
AU - Pijnappel, Ruud M.
AU - Pinker-Domenig, Katja
AU - Skaane, Per
AU - Sardanelli, Francesco
AU - for the European Society of Breast Imaging (EUSOBI), with language review by Europa Donna–The European Breast Cancer Coalition
PY - 2015/12
Y1 - 2015/12
N2 - UNLABELLED: This paper summarizes information about breast MRI to be provided to women and referring physicians. After listing contraindications, procedure details are described, stressing the need for correct scheduling and not moving during the examination. The structured report including BI-RADS® categories and further actions after a breast MRI examination are discussed. Breast MRI is a very sensitive modality, significantly improving screening in high-risk women. It also has a role in clinical diagnosis, problem solving, and staging, impacting on patient management. However, it is not a perfect test, and occasionally breast cancers can be missed. Therefore, clinical and other imaging findings (from mammography/ultrasound) should also be considered. Conversely, MRI may detect lesions not visible on other imaging modalities turning out to be benign (false positives). These risks should be discussed with women before a breast MRI is requested/performed. Because breast MRI drawbacks depend upon the indication for the examination, basic information for the most important breast MRI indications is presented. Seventeen notes and five frequently asked questions formulated for use as direct communication to women are provided. The text was reviewed by Europa Donna-The European Breast Cancer Coalition to ensure that it can be easily understood by women undergoing MRI.KEY POINTS: • Information on breast MRI concerns advantages/disadvantages and preparation to the examination • Claustrophobia, implantable devices, allergic predisposition, and renal function should be checked • Before menopause, scheduling on day 7-14 of the cycle is preferred • During the examination, it is highly important that the patient keeps still • Availability of prior examinations improves accuracy of breast MRI interpretation.
AB - UNLABELLED: This paper summarizes information about breast MRI to be provided to women and referring physicians. After listing contraindications, procedure details are described, stressing the need for correct scheduling and not moving during the examination. The structured report including BI-RADS® categories and further actions after a breast MRI examination are discussed. Breast MRI is a very sensitive modality, significantly improving screening in high-risk women. It also has a role in clinical diagnosis, problem solving, and staging, impacting on patient management. However, it is not a perfect test, and occasionally breast cancers can be missed. Therefore, clinical and other imaging findings (from mammography/ultrasound) should also be considered. Conversely, MRI may detect lesions not visible on other imaging modalities turning out to be benign (false positives). These risks should be discussed with women before a breast MRI is requested/performed. Because breast MRI drawbacks depend upon the indication for the examination, basic information for the most important breast MRI indications is presented. Seventeen notes and five frequently asked questions formulated for use as direct communication to women are provided. The text was reviewed by Europa Donna-The European Breast Cancer Coalition to ensure that it can be easily understood by women undergoing MRI.KEY POINTS: • Information on breast MRI concerns advantages/disadvantages and preparation to the examination • Claustrophobia, implantable devices, allergic predisposition, and renal function should be checked • Before menopause, scheduling on day 7-14 of the cycle is preferred • During the examination, it is highly important that the patient keeps still • Availability of prior examinations improves accuracy of breast MRI interpretation.
KW - Breast
KW - Breast neoplasms
KW - Europe
KW - Female
KW - Humans
KW - Magnetic resonance imaging
KW - Practice guidelines as topic
U2 - 10.1007/s00330-015-3807-z
DO - 10.1007/s00330-015-3807-z
M3 - Article
C2 - 26002130
SN - 0938-7994
VL - 25
SP - 3669
EP - 3678
JO - European Radiology
JF - European Radiology
IS - 12
ER -